Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Study of the Effect of 7-Methylxanthine on the Progression of Childhood Myopia

NCT00263471 is registered in ClinicalTrials.gov with Trier Research Laboratories as lead sponsor.

NCT NCT00263471
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00263471 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Study of the Effect of 7-Methylxanthine on the Progression of Childhood Myopia
Lead sponsor
Trier Research Laboratories
Phase
Phase 2
Overall status
Unknown status
Start date
October 31, 2003
Completion date
March 31, 2006
Enrollment
90
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

myopia